| Product Code: ETC9410496 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market - Industry Life Cycle |
3.4 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market - Porter's Five Forces |
3.5 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.8 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the prevalence of parenteral nutrition-associated cholestasis in South Korea |
4.2.2 Technological advancements in the development of effective treatment options |
4.2.3 Growing healthcare expenditure and focus on improving neonatal care in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory processes for approval of new treatment options |
4.3.2 Limited availability of specialized healthcare professionals in the field of parenteral nutrition-associated cholestasis |
4.3.3 High cost associated with treatment and management of the condition |
5 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Trends |
6 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market, By Types |
6.1 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Lipid Injectable Emulsion, 2021- 2031F |
6.1.4 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Fish Oil Triglyceride, 2021- 2031F |
6.1.5 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Ursodeoxycholic Acid, 2021- 2031F |
6.1.6 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.3 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Drugs, 2021- 2031F |
6.2.4 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market, By Mode of Administration |
6.3.1 Overview and Analysis |
6.3.2 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.3 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.4 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Import-Export Trade Statistics |
7.1 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Export to Major Countries |
7.2 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Imports from Major Countries |
8 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Key Performance Indicators |
8.1 Patient recovery rate after treatment |
8.2 Average length of hospital stay for patients undergoing treatment |
8.3 Adoption rate of new treatment modalities in clinical practice |
8.4 Rate of recurrence of parenteral nutrition-associated cholestasis |
8.5 Patient satisfaction scores with the treatment received |
9 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market - Opportunity Assessment |
9.1 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.4 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Opportunity Assessment, By End User, 2021 & 2031F |
10 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market - Competitive Landscape |
10.1 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Revenue Share, By Companies, 2024 |
10.2 South Korea Parenteral Nutrition-Associated Cholestasis Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here